BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 169296)

  • 1. Insulin receptor deficiency in genetic and acquired obesity.
    Soli AH; Kahn CR; Neville DM; Roth J
    J Clin Invest; 1975 Oct; 56(4):769-80. PubMed ID: 169296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptors in the heart muscle. Demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse.
    Forgue ME; Freychet P
    Diabetes; 1975 Aug; 24(8):715-23. PubMed ID: 169173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlargement of epididymal adipocytes in relation to hyperinsulinemia in obese hyperglycemic mice (ob-ob).
    Joosten HF; van der Kroon PH
    Metabolism; 1974 Jan; 23(1):59-66. PubMed ID: 4808512
    [No Abstract]   [Full Text] [Related]  

  • 4. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin binding to liver plasm membranes in the obese hyperglycemic (ob/ob) mouse. Demonstration of a decreased number of functionally normal receptors.
    Soll AH; Kahn CR; Neville DM
    J Biol Chem; 1975 Jun; 250(12):4702-7. PubMed ID: 167002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.
    Le Marchand Y; Loten EG; Assimacopoulos-Jeannet F; Forgue ME; Freychet P; Jeanrenaud B
    Diabetes; 1977 Jun; 26(6):582-90. PubMed ID: 140828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice.
    Dubuc PU
    Metabolism; 1976 Dec; 25(12):1567-74. PubMed ID: 994838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.
    Igel M; Becker W; Herberg L; Joost HG
    Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat.
    Soll AH; Goldfine ID; Roth J; Kahn CR
    J Biol Chem; 1974 Jul; 249(13):4127-31. PubMed ID: 4369380
    [No Abstract]   [Full Text] [Related]  

  • 12. Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice.
    Saito M; Bray GA
    Endocrinology; 1983 Dec; 113(6):2181-5. PubMed ID: 6416815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin receptor gene and its expression in insulin-resistant mice.
    Ludwig S; Muller-Wieland D; Goldstein BJ; Kahn CR
    Endocrinology; 1988 Jul; 123(1):594-600. PubMed ID: 2838265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal obesities.
    Jeanrenaud B
    Ann Nutr Aliment; 1979; 33(1):27-38. PubMed ID: 382957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glucose and lipid metabolism in genetically obese mice lacking aP2.
    Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS
    Endocrinology; 2000 Sep; 141(9):3388-96. PubMed ID: 10965911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decreased number of insulin receptors in obesity: studies in the obese hyperglycemic mouse (author's transl)].
    Freychet P; Forgue E; Le Marchand Y; Laudat MH
    Ann Endocrinol (Paris); 1976; 37(2):87-8. PubMed ID: 1008511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different genes for obesity are associated with insulin loss of regulation of the membrane (Ca2+ + Mg2+)-ATPase in the obesity syndrome. Lessons from animal models.
    Levy J; Gavin JR
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):97-102. PubMed ID: 7735347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H
    Carcinogenesis; 2004 May; 25(5):821-5. PubMed ID: 14729596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in hepatic but not in renal and vascular vasopressin receptor number in hyperinsulinemic mice and rats.
    Cantau B; Guillon G; Mathieu MN; Vidal-Chicot D; Chevillard C
    Mol Cell Endocrinol; 1984 Dec; 38(2-3):131-9. PubMed ID: 6096184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.